Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cell-Derived Exosome Therapy for Facial Skin Quality
NCT07466953Phase 3Not yet recruiting
- Start
- Jul 2026
- Primary completion
- Nov 2026
- Modality
- Lipid-based Nanoparticles, Cell Therapies
01
Overview
A Phase 3 trial of Mesenchymal stem cell-derived exosome in Skin aging. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
Mesenchymal stem cell-derived exosome
03
Conditions
Skin aging
Beyond the preview
Go deeper on NCT07466953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07466953.